2020 Q3 Form 10-Q Financial Statement

#000163982520000175 Filed on November 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $757.9M $228.0M
YoY Change 232.41% 103.39%
Cost Of Revenue $429.2M $122.9M
YoY Change 249.23% 102.81%
Gross Profit $328.7M $105.1M
YoY Change 212.75% 104.08%
Gross Profit Margin 43.37% 46.1%
Selling, General & Admin $223.2M $138.5M
YoY Change 61.16% 45.03%
% of Gross Profit 67.9% 131.78%
Research & Development $36.60M $17.40M
YoY Change 110.34% 50.0%
% of Gross Profit 11.13% 16.56%
Depreciation & Amortization $11.40M $7.100M
YoY Change 60.56% 69.05%
% of Gross Profit 3.47% 6.76%
Operating Expenses $259.8M $156.0M
YoY Change 66.54% 45.66%
Operating Profit $68.90M -$50.90M
YoY Change -235.36% -8.45%
Interest Expense $400.0K $1.300M
YoY Change -69.23% 30.0%
% of Operating Profit 0.58%
Other Income/Expense, Net $1.700M $1.200M
YoY Change 41.67% 20.0%
Pretax Income $70.60M -$49.70M
YoY Change -242.05% -8.81%
Income Tax $1.300M $100.0K
% Of Pretax Income 1.84%
Net Earnings $69.30M -$49.80M
YoY Change -239.16% -8.62%
Net Earnings / Revenue 9.14% -21.84%
Basic Earnings Per Share $0.24 -$1.29
Diluted Earnings Per Share $0.20 -$1.29
COMMON SHARES
Basic Shares Outstanding 288.7M shares 38.45M shares
Diluted Shares Outstanding 342.1M shares 38.45M shares

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.023B $1.476B
YoY Change 37.02%
Cash & Equivalents $1.431B $1.376B
Short-Term Investments $592.3M $100.4M
Other Short-Term Assets $146.3M $46.50M
YoY Change 214.62%
Inventory $364.0M $205.6M
Prepaid Expenses
Receivables $49.90M $20.90M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.583B $1.749B
YoY Change 47.66%
LONG-TERM ASSETS
Property, Plant & Equipment $295.5M $119.7M
YoY Change 146.87%
Goodwill $39.70M $4.300M
YoY Change 823.26%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.40M $9.900M
YoY Change 166.67%
Total Long-Term Assets $894.5M $638.4M
YoY Change 40.12%
TOTAL ASSETS
Total Short-Term Assets $2.583B $1.749B
Total Long-Term Assets $894.5M $638.4M
Total Assets $3.478B $2.388B
YoY Change 45.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $275.0M $90.70M
YoY Change 203.2%
Accrued Expenses $246.7M $116.2M
YoY Change 112.31%
Deferred Revenue $521.2M $99.20M
YoY Change 425.4%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.094B $327.6M
YoY Change 233.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $29.10M $400.0K
YoY Change 7175.0%
Total Long-Term Liabilities $29.10M $400.0K
YoY Change 7175.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.094B $327.6M
Total Long-Term Liabilities $29.10M $400.0K
Total Liabilities $1.677B $811.8M
YoY Change 106.52%
SHAREHOLDERS EQUITY
Retained Earnings -$624.6M -$672.0M
YoY Change -7.05%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.801B $1.576B
YoY Change
Total Liabilities & Shareholders Equity $3.478B $2.388B
YoY Change 45.64%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $69.30M -$49.80M
YoY Change -239.16% -8.62%
Depreciation, Depletion And Amortization $11.40M $7.100M
YoY Change 60.56% 69.05%
Cash From Operating Activities $312.1M -$76.20M
YoY Change -509.58% 152.32%
INVESTING ACTIVITIES
Capital Expenditures $49.20M $22.50M
YoY Change 118.67% 100.89%
Acquisitions
YoY Change
Other Investing Activities $124.5M $115.3M
YoY Change 7.98%
Cash From Investing Activities $62.40M $92.80M
YoY Change -32.76% -928.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $18.80M $1.198B
YoY Change -98.43% 122.21%
NET CHANGE
Cash From Operating Activities $312.1M -$76.20M
Cash From Investing Activities $62.40M $92.80M
Cash From Financing Activities $18.80M $1.198B
Net Change In Cash $395.0M $1.214B
YoY Change -67.45% 143.81%
FREE CASH FLOW
Cash From Operating Activities $312.1M -$76.20M
Capital Expenditures $49.20M $22.50M
Free Cash Flow $262.9M -$98.70M
YoY Change -366.36% 138.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q3 dei Amendment Flag
AmendmentFlag
false
CY2020Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001639825
CY2020Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
CY2020Q3 dei Document Type
DocumentType
10-Q
CY2020Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q3 dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
CY2020Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q3 dei Entity File Number
EntityFileNumber
001-39058
CY2020Q3 dei Entity Registrant Name
EntityRegistrantName
Peloton Interactive, Inc.
CY2020Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3533761
CY2020Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
125 West 25th Street, 11th Floor
CY2020Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
CY2020Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2020Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2020Q3 dei City Area Code
CityAreaCode
866
CY2020Q3 dei Local Phone Number
LocalPhoneNumber
679-9129
CY2020Q3 dei Security12b Title
Security12bTitle
Class A common stock, $0.000025 par value per share
CY2020Q3 dei Trading Symbol
TradingSymbol
PTON
CY2020Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q3 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1430500000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1035500000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
592300000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
719500000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49900000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34600000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
364000000.0 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
244500000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
146300000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
124500000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
2583000000.0 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
2158600000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
295500000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
242300000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14700000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16000000.0 USD
CY2020Q3 us-gaap Goodwill
Goodwill
39700000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
39100000 USD
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1500000 USD
CY2020Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1500000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
516700000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
492500000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26400000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31800000 USD
CY2020Q3 us-gaap Assets
Assets
3477500000 USD
CY2020Q2 us-gaap Assets
Assets
2981800000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
275000000.0 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
135800000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
246700000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
225900000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
521200000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
363600000 USD
CY2020Q3 pton Operating Lease And Other Liabilities Current
OperatingLeaseAndOtherLiabilitiesCurrent
50800000 USD
CY2020Q2 pton Operating Lease And Other Liabilities Current
OperatingLeaseAndOtherLiabilitiesCurrent
46900000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1093700000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
772200000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
553700000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
508200000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29100000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23400000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
1676500000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
1303800000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2412900000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2361800000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12700000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10100000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-624600000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-693900000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1801000000.0 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1678000000.0 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3477500000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2981800000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
757900000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
228000000.0 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
429200000 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
122900000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
328700000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
105100000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
114600000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
77600000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
108600000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60900000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36600000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17400000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
259800000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
156000000.0 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
68900000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-50900000 USD
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2400000 USD
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1300000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-700000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1700000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1200000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70600000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49700000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
69300000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-49800000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
69300000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-49800000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.29
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.29
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
288719834 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38453864 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
342101984 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38453864 shares
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1300000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3900000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1300000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2600000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1300000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
71900000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51100000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
69300000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-49800000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11400000 USD
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7100000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
29600000 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
18700000 USD
CY2020Q3 pton Noncash Operating Lease Liabilities Net
NoncashOperatingLeaseLiabilitiesNet
13300000 USD
CY2019Q3 pton Noncash Operating Lease Liabilities Net
NoncashOperatingLeaseLiabilitiesNet
9300000 USD
CY2020Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1700000 USD
CY2019Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-300000 USD
CY2020Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1400000 USD
CY2019Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-100000 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15000000.0 USD
CY2019Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2400000 USD
CY2020Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
118000000.0 USD
CY2019Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
69100000 USD
CY2020Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18200000 USD
CY2019Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1900000 USD
CY2020Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5900000 USD
CY2019Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1400000 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
156400000 USD
CY2019Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
17500000 USD
CY2020Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
157400000 USD
CY2019Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8500000 USD
CY2020Q3 pton Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
11300000 USD
CY2019Q3 pton Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-16700000 USD
CY2020Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5500000 USD
CY2019Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-100000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
312100000 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76200000 USD
CY2020Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
124500000 USD
CY2019Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
115300000 USD
CY2020Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
49200000 USD
CY2019Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
19100000 USD
CY2020Q3 pton Capitalization Of Software Costs
CapitalizationOfSoftwareCosts
12900000 USD
CY2019Q3 pton Capitalization Of Software Costs
CapitalizationOfSoftwareCosts
3400000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
62400000 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
92800000 USD
CY2020Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
CY2019Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1195700000 USD
CY2020Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
3300000 USD
CY2019Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0 USD
CY2020Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15400000 USD
CY2019Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2700000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18800000 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1198400000 USD
CY2020Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1700000 USD
CY2019Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1300000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
395000000.0 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1213700000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1037000000.0 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163000000.0 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1432000000.0 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1376700000 USD
CY2020Q3 us-gaap Interest Paid Net
InterestPaidNet
300000 USD
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
500000 USD
CY2019Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020Q3 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2020Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
19600000 USD
CY2019Q3 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
941100000 USD
CY2019Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8900000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
700000 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
400000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-538600000 USD
CY2019Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
6300000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1195700000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
941100000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2500000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19000000.0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1300000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-49800000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1576000000.0 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1678000000.0 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45900000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5100000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2600000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
69300000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1801000000.0 USD
CY2020Q3 us-gaap Use Of Estimates
UseOfEstimates
The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, and expenses and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, content costs for past use reserve, fair value measurements, the incremental borrowing rate associated with lease liabilities, useful lives of property and equipment, product warranty, goodwill and finite-lived intangible assets, accounting for income taxes, stock-based compensation expense, transaction price estimates, the fair values of assets acquired and liabilities assumed in business combinations, contingent consideration, and commitments and contingencies. Actual results may differ from these estimates.
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
757900000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
228000000.0 USD
CY2020Q3 pton Contract With Customer Liability Current Customer Deposits
ContractWithCustomerLiabilityCurrentCustomerDeposits
492800000 USD
CY2020Q2 pton Contract With Customer Liability Current Customer Deposits
ContractWithCustomerLiabilityCurrentCustomerDeposits
341500000 USD
CY2020Q3 pton Contract With Customer Liability Current Deferred Revenue
ContractWithCustomerLiabilityCurrentDeferredRevenue
28500000 USD
CY2020Q2 pton Contract With Customer Liability Current Deferred Revenue
ContractWithCustomerLiabilityCurrentDeferredRevenue
22100000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
22100000 USD
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9500000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
628000000.0 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2600000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
630600000 USD
CY2020Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
38200000 USD
CY2020Q3 pton Debt Securities Available For Sale Excluding Restricted Securities
DebtSecuritiesAvailableForSaleExcludingRestrictedSecurities
592300000 USD
CY2020Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
24100000 USD
CY2020Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
17800000 USD
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
6000000.0 USD
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4600000 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
345900000 USD
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
232500000 USD
CY2020Q3 us-gaap Inventory Gross
InventoryGross
376000000.0 USD
CY2020Q2 us-gaap Inventory Gross
InventoryGross
254900000 USD
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
12000000.0 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
10500000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
364000000.0 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
244500000 USD
CY2020Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4800000 USD
CY2020Q3 pton Content Costs
ContentCosts
2400000 USD
CY2019Q3 pton Content Costs
ContentCosts
2600000 USD
CY2020Q3 pton Accrued Content Cost And Royalties Current
AccruedContentCostAndRoyaltiesCurrent
24500000 USD
CY2019Q3 pton Accrued Content Cost And Royalties Current
AccruedContentCostAndRoyaltiesCurrent
20800000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
66818860 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.57
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3153600000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2155099 shares
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
81.11
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3497582 shares
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.75
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
480418 shares
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.58
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
64995959 shares
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
3655136 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.14
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5596000000.0 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
27318967 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.47
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M18D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2561700000 USD
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
39674590 shares
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
7.41
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2155099 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
33.43
CY2020Q3 pton Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercised Early Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisedEarlyNumberOfShares
20240 shares
CY2020Q3 pton Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercised Early Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisedEarlyWeightedAverageGrantDateFairValue
2.74
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.09
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
477321 shares
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
6.86
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
37676992 shares
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
9.04
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
33.43
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.80
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29600000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18700000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0181
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0020
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
69300000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-49800000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
288719834 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38453864 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.29
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
69300000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-49800000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
288719834 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38453864 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
342101984 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38453864 shares
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.29
CY2020Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
757900000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
228000000.0 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
429200000 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
122900000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
328700000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
105100000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
328700000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
105100000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
114600000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
77600000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
108600000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60900000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36600000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17400000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1700000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1200000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70600000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49700000 USD

Files In Submission

Name View Source Status
0001639825-20-000175-index-headers.html Edgar Link pending
0001639825-20-000175-index.html Edgar Link pending
0001639825-20-000175.txt Edgar Link pending
0001639825-20-000175-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pton-20200930.htm Edgar Link pending
pton-20200930.xsd Edgar Link pending
pton-20200930_cal.xml Edgar Link unprocessable
pton-20200930_def.xml Edgar Link unprocessable
pton-20200930_htm.xml Edgar Link completed
pton-20200930_lab.xml Edgar Link unprocessable
pton-20200930_pre.xml Edgar Link unprocessable
q1fy2110-qexhibit311.htm Edgar Link pending
q1fy2110-qexhibit312.htm Edgar Link pending
q1fy2110-qexhibit321.htm Edgar Link pending
q1fy2110-qexhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending